The Interim Results of a Multicenter study of Safety and Efficacy of Vemurafenib and Cytarbine plus Cladribine Therapy in high-risk Pediatric Langerhans cell Histiocytosis with Braf V600E Mutation

被引：0
|
作者：
Evseev, Dmitry [1 ]
Osipova, Daria [1 ]
Kalinina, Irina [1 ]
Raykina, Elena [1 ]
Popov, Alexander [1 ]
Kotskaya, Natalia [1 ]
Chernyak, Ekaterina [1 ]
Burtsev, Evgeny [2 ]
Bronin, Gleb [2 ]
Tayshikhina, Irina [2 ]
Purbueva, Bazarma [3 ]
Fink, Olesya [3 ]
Pristanskova, Ekaterina [3 ]
Novitchkova, Galina [1 ]
Maschan, Alexey [1 ]
Maschan, Michael [1 ]
机构：
[1] Dmitry Rogachev Natl Res Ctr, Moscow, Russia
[2] Morozovskaya Children City Clin Hosp, Moscow, Russia
[3] Russian Childrens Clin Hosp, Moscow, Russia
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [31] High Prevalence of BRAF V600E Mutations in Langerhans Cell Histiocytosis of Head and Neck in Chinese Patients
    Liu, Xiaoxiao
    Zhang, Ye
    Zhou, Chuan-Xiang
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2019, 27 (08) : 836 - 843
  • [32] CUTANEOUS ADVERSE EVENTS IN CHILDREN TREATED WITH BRAF-INHIBITOR VEMURAFENIB FOR REFRACTORY BRAF (V600E) MUTATED LANGERHANS CELL HISTIOCYTOSIS: A EUROPEAN COHORT STUDY
    Tardieu, Mathilde
    Neron, Amelie
    Duvert-Lehembre, Sophie
    Larabi, Islam Amine
    Visser, Johannes
    Caroline, Hutter
    Sieni, Elena
    Kabbara, Nabil
    Barkaoui, Mohamed
    Milne, Paul
    Haroche, Julien
    Helias-Rodzewicz, Zofia
    Jehanne, Mathilde
    Kolenova, Sasa
    Pagnier, Anne
    Templier, Isabelle
    Therese-Leccia, Marie
    Aladjidi, Nathalie
    Marie-Cardine, Aude
    Plat, Genevieve
    Lutun, Anne
    Heisig, Anne
    Ferster, Alina
    Efremova, Viktoria
    Ahlmann, M.
    Blanc, Laurence
    Nicholson, James
    Lambilliote, Anne
    Lissat, Andrej
    Svojgr, Karel
    Bernard, Fanette
    Evseev, Dmitriy
    Maschan, Michael
    Idbaih, Ahmed
    Slater, Olga
    Minkov, Milen
    Taly, Valerie
    Collin, Matthew
    Alvarez, Jean-Claude
    Emile, Jean-Francois
    Heritier, Sebastien
    Donadieu, Jean
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S46 - S47
  • [33] BRAF-V600E Mutation on Circulating Cell-Free DNA Is a Promising Biomarker of High-Risk Adult Langerhans Cell Histiocytosis
    Kobayashi, Masayuki
    Ohno, Nobuhiro
    Fukuyama, Tomofusa
    Kawamata, Toyotaka
    Uchimaru, Kaoru
    Tojo, Arinobu
    BLOOD, 2014, 124 (21)
  • [34] The BRAF-V600E mutation in circulating cell-free DNA is a promising biomarker of high-risk adult Langerhans cell histiocytosis
    Kobayashi, Masayuki
    Tojo, Arinobu
    BLOOD, 2014, 124 (16) : 2610 - 2611
  • [35] Activating BRAF V600E Mutation in Aggressive Pediatric Langerhans Cell Histiocytosis Demonstration by Allele-specific PCR/Direct Sequencing and Immunohistochemistry
    Mehes, Gabor
    Irsai, Gabor
    Bedekovics, Judit
    Beke, Livia
    Fazakas, Ferenc
    Rozsa, Timea
    Kiss, Csongor
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (12) : 1644 - 1648
  • [36] Value of BRAF V600E in High-Risk Thyroid Nodules with Benign Cytology Results
    Chen, X.
    Zhou, Q.
    Wang, F.
    Zhang, F.
    Du, H.
    Zhang, Q.
    Wu, W.
    Gong, X.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2018, 39 (12) : 2360 - 2365
  • [37] BRAF V600E Expression in Langerhans Cell Histiocytosis Clinical and Immunohistochemical Study on 25 Pulmonary and 54 Extrapulmonary Cases
    Roden, Anja C.
    Hu, Xiaowen
    Kip, Sertac
    Castellar, Edgardo R. Parrilla
    Rumilla, Kandelaria M.
    Vrana, Julie A.
    Vassallo, Robert
    Ryu, Jay H.
    Yi, Eunhee S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (04) : 548 - 551
  • [38] BRAF V600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis
    Zeng, Kaixuan
    Wang, Zhe
    Ohshima, Koichi
    Liu, Yixiong
    Zhang, Weichen
    Wang, Lu
    Fan, Linni
    Li, Mingyang
    Li, Xia
    Wang, Yingmei
    Yu, Zhou
    Yan, Qingguo
    Guo, Shuangping
    Wei, Jie
    Guo, Ying
    ONCOIMMUNOLOGY, 2016, 5 (07):
  • [39] Cobimetinib plus vemurafenib (C plus V) in patients (Pts) with colorectal cancer (CRC) with BRAF V600E mutations: Results from the TAPUR Study
    Klute, Kelsey
    Garrett-Mayer, Elizabeth
    Halabi, Susan
    Mangat, Pam K.
    Nazemzadeh, Reza
    Yost, Kathleen J.
    Butler, Nicole L.
    Perla, Venu
    Schilsky, Richard L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [40] Autologous hematopoietic stem cell transplantation for efficient treatment of multisystem, high-risk, BRAF V600E-negative Langerhans cell histiocytosis
    Pan, Yaozhu
    Xi, Rui
    Wang, Cunbang
    Fang, Lei
    Bai, Jiaofeng
    Cai, Yonggang
    Guo, Min
    Qiao, Ruiyun
    Lan, Xu
    Yin, Jiaojiao
    Yang, Ke
    Bai, Hai
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (09) : 4522 - 4529
12345